Measles Treatment Boom: A Band Aid on a Wound? The recent surge in US measles cases has been met with concern from health experts and policymakers.
With over 2,300 reported cases by July alone, the number of new cases has hit a 35 year high, despite vaccination rates continuing to decline.
Experts like Michael Mina, chief medical officer at Invivyd, a Connecticut based biotech firm working on measles treatments, note that the current situation is "a horrible lack of options when somebody gets exposed.